From smoking to cancers: Novel targets to neuronal nicotinic acetylcholine receptors

Chia-Hwa Lee, Chih-Hsiung Wu, Yuan-Soon Ho

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Cigarette smoking bears a strong etiological association with many neovascularization-related diseases, including cancer, cardiovascular disease, and age-related macular degeneration. Cigarette smoke is a complex mixture of many compounds, including nicotine, which is the major active and addictive component of tobacco. Nicotine and its specific metabolized carcinogens directly bind to nicotinic acetylcholine receptors (nAChRs) on cell membranes and trigger the nAChR signal cascade. The nAChRs were originally thought to be ligand-gated ion channels that modulate physiological processes ranging from neurotransmission to cancer signaling. For several decades, the nAChRs served as a prototypic molecule for neurotransmitter receptors; however, they are now important therapeutic targets for various diseases, including Alzheimer's and Parkinson's diseases, schizophrenia, and even cancer. This paper describes recent advances in our understanding of the assembly, activity, and biological functions of nicotinic receptors, as well as developments in the therapeutic application of nicotinic receptor ligands.

Original languageEnglish
Article number693424
JournalJournal of Oncology
DOIs
Publication statusPublished - 2011

Fingerprint

Nicotinic Receptors
Smoking
Neoplasms
Nicotine
Physiological Phenomena
Ligand-Gated Ion Channels
Neurotransmitter Receptor
Macular Degeneration
Complex Mixtures
Smoke
Tobacco Products
Synaptic Transmission
Carcinogens
Tobacco
Parkinson Disease
Schizophrenia
Alzheimer Disease
Cardiovascular Diseases
Cell Membrane
Ligands

ASJC Scopus subject areas

  • Oncology

Cite this

From smoking to cancers : Novel targets to neuronal nicotinic acetylcholine receptors. / Lee, Chia-Hwa; Wu, Chih-Hsiung; Ho, Yuan-Soon.

In: Journal of Oncology, 2011.

Research output: Contribution to journalReview article

@article{c5671f87b1ee4f959e98a8d9f662614c,
title = "From smoking to cancers: Novel targets to neuronal nicotinic acetylcholine receptors",
abstract = "Cigarette smoking bears a strong etiological association with many neovascularization-related diseases, including cancer, cardiovascular disease, and age-related macular degeneration. Cigarette smoke is a complex mixture of many compounds, including nicotine, which is the major active and addictive component of tobacco. Nicotine and its specific metabolized carcinogens directly bind to nicotinic acetylcholine receptors (nAChRs) on cell membranes and trigger the nAChR signal cascade. The nAChRs were originally thought to be ligand-gated ion channels that modulate physiological processes ranging from neurotransmission to cancer signaling. For several decades, the nAChRs served as a prototypic molecule for neurotransmitter receptors; however, they are now important therapeutic targets for various diseases, including Alzheimer's and Parkinson's diseases, schizophrenia, and even cancer. This paper describes recent advances in our understanding of the assembly, activity, and biological functions of nicotinic receptors, as well as developments in the therapeutic application of nicotinic receptor ligands.",
author = "Chia-Hwa Lee and Chih-Hsiung Wu and Yuan-Soon Ho",
year = "2011",
doi = "10.1155/2011/693424",
language = "English",
journal = "Journal of Oncology",
issn = "1687-8450",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - From smoking to cancers

T2 - Novel targets to neuronal nicotinic acetylcholine receptors

AU - Lee, Chia-Hwa

AU - Wu, Chih-Hsiung

AU - Ho, Yuan-Soon

PY - 2011

Y1 - 2011

N2 - Cigarette smoking bears a strong etiological association with many neovascularization-related diseases, including cancer, cardiovascular disease, and age-related macular degeneration. Cigarette smoke is a complex mixture of many compounds, including nicotine, which is the major active and addictive component of tobacco. Nicotine and its specific metabolized carcinogens directly bind to nicotinic acetylcholine receptors (nAChRs) on cell membranes and trigger the nAChR signal cascade. The nAChRs were originally thought to be ligand-gated ion channels that modulate physiological processes ranging from neurotransmission to cancer signaling. For several decades, the nAChRs served as a prototypic molecule for neurotransmitter receptors; however, they are now important therapeutic targets for various diseases, including Alzheimer's and Parkinson's diseases, schizophrenia, and even cancer. This paper describes recent advances in our understanding of the assembly, activity, and biological functions of nicotinic receptors, as well as developments in the therapeutic application of nicotinic receptor ligands.

AB - Cigarette smoking bears a strong etiological association with many neovascularization-related diseases, including cancer, cardiovascular disease, and age-related macular degeneration. Cigarette smoke is a complex mixture of many compounds, including nicotine, which is the major active and addictive component of tobacco. Nicotine and its specific metabolized carcinogens directly bind to nicotinic acetylcholine receptors (nAChRs) on cell membranes and trigger the nAChR signal cascade. The nAChRs were originally thought to be ligand-gated ion channels that modulate physiological processes ranging from neurotransmission to cancer signaling. For several decades, the nAChRs served as a prototypic molecule for neurotransmitter receptors; however, they are now important therapeutic targets for various diseases, including Alzheimer's and Parkinson's diseases, schizophrenia, and even cancer. This paper describes recent advances in our understanding of the assembly, activity, and biological functions of nicotinic receptors, as well as developments in the therapeutic application of nicotinic receptor ligands.

UR - http://www.scopus.com/inward/record.url?scp=80052668790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052668790&partnerID=8YFLogxK

U2 - 10.1155/2011/693424

DO - 10.1155/2011/693424

M3 - Review article

C2 - 21772846

AN - SCOPUS:80052668790

JO - Journal of Oncology

JF - Journal of Oncology

SN - 1687-8450

M1 - 693424

ER -